Aspirin Consumption and Severity of Reye's Syndrome

PEDIATRICS ◽  
1983 ◽  
Vol 71 (2) ◽  
pp. 294-295
Author(s):  
KAREN M. STARKO
Keyword(s):  
Infectious Diseases ◽  
American Academy ◽  
Disease Control ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Case Control ◽  
Reye's Syndrome ◽  
American Academy Of Pediatrics ◽  
Confounding Variables

In Reply.— The Center for Disease Control,1 the Committee on Infectious Diseases of the American Academy of Pediatrics,2 and The Food and Drug Administration,3 have concluded that the studies conducted in Arizona,4 Michigan,5 and Ohio6 indicate that a statistically significant association exists between Reye's syndrome (RS) and salicylate use. Reasons for this association being false, such as case-control misclassification, the influence of confounding variables (fever, headache) etc, have been addressed by these groups. Although concerns have been raised regarding these factors, none has been shown to account for the association.

Drugs (e.g., Hexachiorophene), the FDA, and the AAP

PEDIATRICS ◽  
1972 ◽  
Vol 50 (2) ◽  
pp. 338-338
Author(s):  
Ira Marks
Keyword(s):  
American Academy ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
American Academy Of Pediatrics ◽  
Set Up ◽  
Available Information

Although it is now six months since the Food and Drug Administration (FDA) originally approached the American Academy of Pediatrics regarding the potential dangers of hexachlorophene, the Academy (through its Committee on Fetus and Newborn) still seems to be basing its decision on three (unconfirmed) studies referred to in the FDA Bulletin of December 1971. If the Academy is to become involved in the FDA decision (and I agree that it should) is it not mandatory that we set up specific criteria that must be met before we agree or disagree with any FDA announcement? Simply because the FDA does, must we feel obliged to make decisions on the basis of a few studies which have been repeated by no one? Apparently the Committee has felt so, since it made its recommendation after "reviewing all the available information," i.e., a few unconfirmed studies.

Alkalosis in Infancy and Commercial Formulas

PEDIATRICS ◽  
1980 ◽  
Vol 65 (3) ◽  
pp. 639-641
Author(s):  
Malcolm A. Holliday
Keyword(s):  
Sodium Chloride ◽  
American Academy ◽  
Drug Administration ◽  
Infant Nutrition ◽  
Food And Drug Administration ◽  
Chloride Content ◽  
Sodium Content ◽  
Infant Formulas ◽  
American Academy Of Pediatrics ◽  
Recent Occurrence

The recent occurrence of alkalosis in infants fed Neo-Mullsoy has raised a number of points concerning infant nutrition. Two products, Neo-Mullsoy and CHO-free had levels of sodium and chloride below standards recommended by the Committee on Nutrition of the American Academy of Pediatrics.1 Regulations of the Food and Drug Administration (FDA) concerning infant formulas do not cover sodium chloride content.2 The company intended its products to meet the recommendations made by the Committee on Nutrition,1 but a number of changes in manufacturing practices led to the products containing less sodium and, learned after the fact, very little chloride. The sodium content of most batches while below recommended levels1 probably met minimum needs for virtually all infants.

The Recommended Childhood Immunization Schedule of the United States

PEDIATRICS ◽  
1995 ◽  
Vol 95 (1) ◽  
pp. 135-137 ◽  
Author(s):  
Caroline Breese Hall
Keyword(s):  
United States ◽  
Infectious Diseases ◽  
American Academy ◽  
Disease Control ◽  
Advisory Committee ◽  
The United States ◽  
Routine Immunization ◽  
Immunization Schedule ◽  
Childhood Immunization ◽  
American Academy Of Pediatrics

The complexity of our current schedule for routine immunization of children is expanding and experienced by both physician and parent. Over nearly two decades in the 1970s and 1980s only one new vaccine was added to the routine immunization for children. However, in the last few years since 1989, the schedule routinely recommended for children has been augmented by eight to ten new doses or vaccines. The confusion has been compounded by differences in the schedules developed by the American Academy of Pediatrics' (AAP) Committee on Infectious Diseases and that of the Centers for Disease Control Advisory Committee on Immunization Practices (ACIP).

Tuberculin Testing in the Pediatric Office and Clinic

PEDIATRICS ◽  
1979 ◽  
Vol 64 (6) ◽  
pp. 965-966
Author(s):  
Edwin L. Kendig
Keyword(s):  
American Academy ◽  
Disease Control ◽  
School Children ◽  
Tuberculin Test ◽  
Pediatric Clinic ◽  
American Academy Of Pediatrics ◽  
Tuberculin Testing ◽  
The Difference ◽  
Low Rate

Another article in this issue of Pediatrics, "Assessment of Tuberculin Screening in an Urban Pediatric Clinic," (p 856) again focuses attention on a weighty question: Is routine use of the tuberculin test important? The authors have pointed out the difference in philosophy of the Center for Disease Control, and the American Academy of Pediatrics. The Center for Disease Control recommends that routine tuberculin testing for school children and other similar programs be abandoned if the yield of positive tuberculin reactions is less than 1%1; this recommendation is based on the assumption that discovery of cases at this low rate will not have epidemiologic impact (italics added).

Report of the Committee on Therapeutic Procedures for Acute Infectious Diseases and on Biologicals of the American Academy of Pediatrics

PEDIATRICS ◽  
1948 ◽  
Vol 1 (2) ◽  
pp. 301-301
Keyword(s):  
Infectious Diseases ◽  
American Academy ◽  
American Academy Of Pediatrics ◽  
Therapeutic Procedures ◽  
Antibiotic Agents

A complete revision with a new chapter on Quarantine and Isolation. Chapter 2 on Chemotherapy and Chapter 3 on Antibiotic Agents have been extensively revised. An authoritative statement of the most recent and acceptable information.

Health Supervision Visits: Should the Immunization Schedule Drive the System?

PEDIATRICS ◽  
1987 ◽  
Vol 79 (4) ◽  
pp. 581-582
Author(s):  
ROBERT J. HAGGERTY
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Immunization Schedule ◽  
Health Supervision ◽  
American Academy Of Pediatrics ◽  
Centers For Disease Control ◽  
Well Child Visit ◽  
Child Visit

The Centers for Disease Control (CDC) recently recommended that the vaccines usually given at the 15- and 18-month visits could be given simultaneously at 15 months, thereby omitting the 18-month well-child visit. There is little doubt that measles-mumps-rubella (MMR) immunization, now recommended by the American Academy of Pediatrics to be given at 15 months of age, and the diphtheria-tetanus-pertussis (DTP) and oral polio booster immunizations, now recommended to be given at 18 months of age, could be given together with no problem at 15 months. But this is not a good enough reason to abandon the 18-month well-child visit. Although I will not argue that we have solid evidence for the effectiveness of any well-child procedures other than immunizations, I believe that the 18-month visit is one of the more important ones and should not be discontinued for all children.

Sign in / Sign up

Export Citation Format

Share Document